Postdoctoral Fellow-MSH-30025-237 @ Mount Sinai Health System | Jobright.ai
JOBSarrow
RecommendedLiked
0
Applied
0
External
0
Postdoctoral Fellow-MSH-30025-237 jobs in United States
Be an early applicantLess than 25 applicants
company-logo

Mount Sinai Health System · 18 hours ago

Postdoctoral Fellow-MSH-30025-237

ftfMaximize your interview chances
Health CareHospital
check
Actively Hiring

Insider Connection @Mount Sinai Health System

Discover valuable connections within the company who might provide insights and potential referrals.
Get 3x more responses when you reach out via email instead of LinkedIn.

Responsibilities

The research study focuses on functional genomics and mouse models to understand the consequences of genetic and epigenetic alterations in lung cancer.
You will participate in research to achieve a systematic and comprehensive understanding of the mechanisms of DNA repair, DNA damage responses, phenotypic plasticity, immune regulatory pathways, and immune escape mechanisms in human malignancies with a primary focus on lung cancer.
You will employ in vitro and in vivo models of lung cancer, multiple high-throughput screening technologies, genomics, proteomics, CRISPR engineering, and clinical samples to assess DNA repair, DNA damage responses, and immune sensing pathways, and evaluate their effects on therapeutic response.
You will apply advanced molecular assays including CRISPR screening, immunological analysis, pharmacological evaluations, single-cell RNAseq, and/or spatial transcriptomics to provide critical insights into the molecular circuitry that drives lung cancers and, consequently, results in the development of novel therapeutic strategies for the clinically relevant molecular subsets of lung cancer.

Qualification

Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.

DNA repairDNA damage responsesCRISPR engineeringPhenotypic plasticityImmune regulatory pathwaysImmune escape mechanismsVitro modelsVivo modelsHigh-throughput screeningGenomicsProteomicsSingle-cell RNAseqSpatial transcriptomicsImmunological analysisPharmacological evaluations

Required

PhD
Experience Required: yes

Company

Mount Sinai Health System

company-logo
Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.

Funding

Current Stage
Late Stage
Total Funding
$34.9M
Key Investors
Hearst Health Prize.Multiple Myeloma Research FoundationSteven & Alexandra Cohen Foundation
2024-06-06Grant· $0.1M
2023-11-02Grant· $7M
2023-09-20Grant· $6.2M

Leadership Team

leader-logo
Vincent Tammaro
Executive Vice President and Chief Financial Officer
linkedin
leader-logo
Beth Oliver
Senior Vice President and Chief Nursing Executive
linkedin
Company data provided by crunchbase
logo

Orion

Your AI Copilot